13 Jenkins HE, Tolman AW, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014 383: 1572–1579. 14 Seddon JA, Shingadia D. Epidemiology and disease burden of tuberculosis in children: a global perspective. Infect Drug Resist 2014 7: 153–165. 15 du Preez K, Gabardo BMA, Kabra SK, et al. Priority activities in child and adolescent tuberculosis to close the policy-practice gap in low- and middle-income countries. Pathogens 2022 11: 196. 16 Gidado M, Mitchell EMH, Adejumo AO, et al. Assessment of TB underreporting by level of reporting system in Lagos, Nigeria. Public Health Action 2022 12: 115–120. 17 Fatima R, Yaqoob A, Qadeer E, et al. Measuring and addressing the childhood tuberculosis reporting gaps in Pakistan: the first ever national inventory study among children. PLoS One 2019 14: e0227186. 18 Linn AR, Steenhoff A. Interventions to address the global underreporting of pediatric and adolescent tuberculosis: a systematic review. Open Forum Infect Dis 2022 9: Suppl. 2, ofac492.1265. 19 Seddon JA, Chiang SS, Esmail H, et al. The wonder years: what can primary school children teach us about immunity to Mycobacterium tuberculosis? Front Immunol 2018 9: 2946. 20 Rachow A, Walker NF, Allwood B, et al. The challenge of post-tuberculosis lung disease. In: García-Basteiro AL, Öner Eyüboğlu F, Rangaka MX, eds. The Challenge of Tuberculosis in the 21st Century (ERS Monograph). Sheffield, European Respiratory Society, 2023 pp. 191–209. 21 Marais BJ. Childhood tuberculosis: epidemiology and natural history of disease. Indian J Pediatr 2011 78: 321–327. 22 Dodd PJ, Prendergast AJ, Beecroft C, et al. The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis. Thorax 2017 72: 559–575. 23 Martinez L, Cords O, Horsburgh CR, et al. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet 2020 395: 973–984. 24 Migliori GB, Marx FM, Ambrosino N, et al. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis 2021 25: 797–813. 25 WHO. WHO Consolidated Guidelines on Tuberculosis: Module 5: Management of Tuberculosis in Children and Adolescents: Web Annex 5: Overview of Consolidated WHO Recommendations. Geneva, WHO, 2022. 26 Goletti D, Delogu G, Matteelli A, et al. The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. Int J Infect Dis 2022 124: Suppl. 1, S12–S19. 27 WHO. WHO Operational Handbook on Tuberculosis: Module 5: Management of Tuberculosis in Children and Adolescents. Geneva, WHO, 2022. 28 WHO. Rapid Communication: TB Antigen-based Skin Tests for the Diagnosis of TB Infection. Geneva, WHO, 2022. 29 International Union Against Tuberculosis and Lung Disease. Diagnostic CXR Atlas for Tuberculosis in Children: a Guide to Chest X-ray Interpretation. Paris, International Union Against Tuberculosis and Lung Disease, 2022. 30 WHO. WHO Operational Handbook on Tuberculosis: Module 2: Screening: Systematic Screening for Tuberculosis Disease. Geneva, WHO, 2022. 31 Heller T, Wallrauch C, Goblirsch S, et al. Focused assessment with sonography for HIV-associated tuberculosis (FASH): a short protocol and a pictorial review. Crit Ultrasound J 2012 4: 21. 32 Gunasekera KS, Marcy O, Muñoz J, et al. Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis. Lancet Child Adolesc Health 2023 7: 336–346. 33 Kaforou M, Broderick C, Vito O, et al. Transcriptomics for child and adolescent tuberculosis. Immunol Rev 2022 309: 97–122. 34 Togun TO, MacLean E, Kampmann B, et al. Biomarkers for diagnosis of childhood tuberculosis: a systematic review. PLoS One 2018 13: e0204029. 35 Anderson ST, Kaforou M, Brent AJ, et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Eng J Med 2014 370: 1712–1723. 36 WHO. WHO Operational Handbook on Tuberculosis: Module 1: Prevention: Tuberculosis Preventive Treatment. Geneva, WHO, 2020. 37 Vasiliu A, Salazar-Austin N, Trajman A, et al. Child contact case management – a major policy-practice gap in high-burden countries. Pathogens 2021 11: 1. 38 Osman M, Lee K, du Preez K, et al. Excellent treatment outcomes in children treated for tuberculosis under routine operational conditions in Cape Town, South Africa. Clin Infect Dis 2017 65: 1444–1452. 39 Turkova A, Wills GH, Wobudeya E, et al. Shorter treatment for nonsevere tuberculosis in African and Indian children. N Engl J Med 2022 386: 911–922. 40 Dorman SE, Nahid P, Kurbatova EV, et al. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis. N Engl J Med 2021 384: 1705–1718. 41 Gafar F, Wasmann RE, McIlleron HM, et al. Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis. Eur Respir J 2023 61: 2201596. 232 https://doi.org/10.1183/2312508X.10025322 ERS MONOGRAPH |THE CHALLENGE OF TB IN THE 21ST CENTURY